نتایج جستجو برای: alcoholic fatty liver disease nafld

تعداد نتایج: 1835563  

2015
M. V. Jali Sanjay Kambar Sujata M. Jali Murigendra B. Hiremath

Background: The prevalence of non-alcoholic fatty liver disease (NAFLD), has been estimated to be between 20% and 30% in the general population, but this value is much higher (approximately 70-80%) in type 2 diabetes patients, who are also at higher risk of developing advanced fibrosis and cirrhosis As a result of epidemic increase in obesity, hyperlipidemia and diabetes mellitus patients, the ...

Journal: :Hepatobiliary surgery and nutrition 2015
Bahiddin Yilmaz Kazim Sahin Hande Bilen Ibrahim H Bahcecioglu Birdal Bilir Sara Ashraf Karim J Halazun Omer Kucuk

Non-alcoholic fatty liver disease (NAFLD) is a growing health problem around the world, especially in developed countries. NAFLD includes all cases of fatty liver disease from simple steatosis to cirrhosis, without excessive alcohol intake, use of steatogenic medication or hereditary disorders. Pathogenesis is associated with dietary high fat intake, decreased free fatty acid (FFA) oxidation, i...

2010
Anna Kotronen Hannele Yki-Järvinen Satu Männistö Liisa Saarikoski Eeva Korpi-Hyövälti Heikki Oksa Juha Saltevo Timo Saaristo Jouko Sundvall Jaakko Tuomilehto Markku Peltonen

BACKGROUND Non-alcoholic fatty liver disease (NAFLD) is known to be associated with the metabolic syndrome (MetS) and abnormal glucose tolerance. Whether alcoholic fatty liver disease (AFLD) is associated with similar metabolic abnormalities has not been examined in a population-based study. We aimed at assessing the prevalences of NAFLD and AFLD, and to examine to what extent these conditions ...

2009
Stefano Gitto Erica Villa

Non-alcoholic fatty liver disease (NAFLD) is a clinicopathologic entity increasingly recognized as a major health burden in developed countries. It includes a spectrum of liver damage ranging from simple steatosis to nonalcoholic steatohepatitis (NASH), advanced fibrosis, and rarely, progression to cirrhosis. Recent studies emphasize the role of insulin resistance, oxidative stress and subseque...

2015
Hannele Yki-Järvinen

Non-alcoholic fatty liver disease (NAFLD) covers a spectrum of disorders ranging from simple steatosis (non-alcoholic fatty liver, NAFL) to non-alcoholic steatohepatitis (NASH) and cirrhosis. NAFL increases the risk of liver fibrosis. If the liver is fatty due to causes of insulin resistance such as obesity and physical inactivity, it overproduces glucose and triglycerides leading to hyperinsul...

Journal: : 2021

Objective of the Review: To analyse available information on various aspects non-alcoholic fatty liver disease (NAFLD). Key Points. A group international experts proposed to replace terms “NAFLD” with “metabolism-associated disease” (MAFLD) which, in opinion experts, more adequately reflects nature disease. The proposal is related fact that associated multi system disorders and a heterogeneous ...

2012
Masato Yoneda Shuhei Naka Kazuhiko Nakano Koichiro Wada Hiroki Endo Hironori Mawatari Kento Imajo Ryota Nomura Kazuya Hokamura Masafumi Ono Shogo Murata Iwai Tohnai Yoshio Sumida Toshihide Shima Masae Kuboniwa Kazuo Umemura Yoshinori Kamisaki Atsuo Amano Takeshi Okanoue Takashi Ooshima Atsushi Nakajima

BACKGROUND Non-alcoholic fatty liver disease (NAFLD) is a hepatic manifestation of metabolic syndrome that is closely associated with multiple factors such as obesity, hyperlipidemia and type 2 diabetes mellitus. However, other risk factors for the development of NAFLD are unclear. With the association between periodontal disease and the development of systemic diseases receiving increasing att...

2016
Stavros Bashiardes Hagit Shapiro Shachar Rozin Oren Shibolet Eran Elinav

BACKGROUND Non-alcoholic fatty liver (NAFLD) is a common, multi-factorial, and poorly understood liver disease whose incidence is globally rising. NAFLD is generally asymptomatic and associated with other manifestations of the metabolic syndrome. Yet, up to 25% of NAFLD patients develop a progressive inflammatory liver disease termed non-alcoholic steatohepatitis (NASH) that may progress toward...

Journal: :European medical journal 2022

Non-alcoholic steatohepatitis (NASH) is the potentially progressive form of non-alcoholic fatty liver disease (NAFLD). NAFLD and NASH are very common in most regions world on trajectory to become at a global scale. Risk for high prevalence progressiveness include visceral obesity Type 2 diabetes. The conundrum related rapid increase its burden with low awareness among general providers, as well...

Journal: :Pakistan journal of pharmaceutical sciences 2018
Abdus Saboor Shah Shahzeb Khan Haroon Rahim Kamran Ahmad Chishti Aamir Ghafoor Khan

Non-alcoholic fatty liver disease prevalence has not been well established. The aims of this study was to define prospectively non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD) prevalence in hospitalized and ambulatory patients 20-65 years old during June 2013 to June 2014 were selected from Combined Military Hospital Peshawar Cantonment area. A base line questi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید